Hoth Therapeutics, Inc. Quarterly Return On Assets in % from Q3 2019 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Hoth Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from Q3 2019 to Q2 2024.
  • Hoth Therapeutics, Inc. Return On Assets for the quarter ending June 30, 2024 was -74.4 %, a 23.2% increase year-over-year.
  • Hoth Therapeutics, Inc. annual Return On Assets for 2023 was -66.8 %, a 44.4% increase from 2022.
  • Hoth Therapeutics, Inc. annual Return On Assets for 2022 was -120 %, a 36.8% decline from 2021.
  • Hoth Therapeutics, Inc. annual Return On Assets for 2021 was -87.8 %, a 26.9% increase from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -74.4 +22.5 +23.2% Apr 1, 2024 Jun 30, 2024
Q1 2024 -73.3 +30.4 +29.3% Jan 1, 2024 Mar 31, 2024
Q4 2023 -66.8 +53.4 +44.4% Oct 1, 2023 Dec 31, 2023
Q3 2023 -87 +21.1 +19.5% Jul 1, 2023 Sep 30, 2023
Q2 2023 -96.9 +4.68 +4.61% Apr 1, 2023 Jun 30, 2023
Q1 2023 -104 -8.7 -9.16% Jan 1, 2023 Mar 31, 2023
Q4 2022 -120 -32.4 -36.8% Oct 1, 2022 Dec 31, 2022
Q3 2022 -108 -30.1 -38.7% Jul 1, 2022 Sep 30, 2022
Q2 2022 -102 -18.6 -22.4% Apr 1, 2022 Jun 30, 2022
Q1 2022 -95 +2.27 +2.33% Jan 1, 2022 Mar 31, 2022
Q4 2021 -87.8 +32.3 +26.9% Oct 1, 2021 Dec 31, 2021
Q3 2021 -78 +114 +59.4% Jul 1, 2021 Sep 30, 2021
Q2 2021 -82.9 +116 +58.4% Apr 1, 2021 Jun 30, 2021
Q1 2021 -97.3 +108 +52.6% Jan 1, 2021 Mar 31, 2021
Q4 2020 -120 +60.6 +33.5% Oct 1, 2020 Dec 31, 2020
Q3 2020 -192 -73.1 -61.5% Jul 1, 2020 Sep 30, 2020
Q2 2020 -199 Apr 1, 2020 Jun 30, 2020
Q1 2020 -205 Jan 1, 2020 Mar 31, 2020
Q4 2019 -181 Oct 1, 2019 Dec 31, 2019
Q3 2019 -119 Jul 1, 2019 Sep 30, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.